Baloxavir marboxil and Oseltamivir in patients with influenza A, demonstrating that Baloxavir produced faster symptom resolution when administered early, with no increase in adverse events and consistent real-world effectiveness Host-directed strategies are represented by Sun et al.,(https://doi.org/10.3389/fmicb.2025.1591473) who evaluated the regulatory role of RIOK3 in respiratory syncytial virus (RSV) infection. RIOK3 deletion impaired type I interferon signaling, increased viral replication, and altered macrophage inflammatory responses, highlighting RIOK3 as a potential therapeutic target for modulating innate immunity and reducing immunopathology Finally, Coppola et al. (https://doi.org/10.3389/fmicb.2025.1592647) provide an innovative perspective on synergistic immune protection in lentiviral infection, demonstrating that combined use of Rhesus cytomegalovirus-vectored SIV vaccines and neutralizing antibodies enhances viral control following challenge, beyond the effects of either modality aloneSeveral contributions address SARS-CoV-2 from molecular, computational, clinical, and methodological perspectives, underscoring the continued need for multidisciplinary research amid ongoing viral endemicity.(https://doi.org/10.3389/fmicb.2024.1438827) report a compelling case series of two very elderly patients co-infected with hepatitis C virus (HCV) and SARS-CoV-2 who were successfully treated with sequential antiviral therapy-sofosbuvir/velpatasvir followed by nirmatrelvir/ritonavir-resulting in complete clearance of both viruses without adverse reactions, and sustained HCV remission after nine months. with bimodal age peaks in young and older women. High-risk genotypes HPV52, HPV58, and HPV16 predominated, and hr-HPV positivity was strongly associated with cytologic and histopathologic abnormalities, especially in CIN II/III lesions. Importantly, agestratified analysis revealed declines in vaccine-preventable genotypes among women under 30 following the rapid uptake of nonavalent vaccination since 2022.At the molecular level, Cao et al. (https://doi.org/10.3389/fmicb.2024.1515258) investigated the functional impact of the P16L variant of HPV16 E5, showing that the substitution enhances proliferation, migration, and colony formation while inhibiting apoptosis in epithelial cells. Variants influenced the expression of Cyclin D1 and BAX, suggesting that naturally occurring oncoprotein polymorphisms may modulate oncogenic potential and contribute to clinical heterogeneity Together, these studies highlight both the population-level success of vaccination programs and the importance of understanding viral genetic variation that may influence pathogenicity.The Special Issue brings together a diverse body of research examining emerging pathogens across human, veterinary, and vector-borne systems, collectively underscoring the essential role of integrated genomic, ecological, and epidemiological surveillance. Within this context, Salem et al. (https://doi.org/10.3389/fimmu.2025.1560851) offer a conceptual contribution that elucidates the phenomenon of immune imprinting across orthoflaviviruses. Their analysis demonstrates how original antigenic sin can shape the hierarchy of memory B-cell responses following sequential flavivirus exposures, at times producing cross-neutralizing protection but in other circumstances favoring nonneutralizing antibody profiles capable of driving antibody-dependent enhancement, particularly in dengue. The immunological model presented illustrates the delicate balance between immune memory and viral escape and highlights the need for vaccines designed to elicit broad, cross-reactive immunity across diverse antigenic landscapes.A complementary example of viral emergence in the veterinary context is provided by Goraichuk et al., (https://doi.org/10.3389/fmicb.2024.1428248), who document the first detection of avian metapneumovirus subtype A (aMPV-A) in the United States. By sequencing complete and near-complete viral genomes, the authors identify previously unreported mutations in the G glycoprotein, a key determinant of receptor binding and tissue tropism. Their validation of a refined RT-qPCR assay capable of differentiating viral subtypes with high sensitivity enhances the diagnostic capacity necessary for early detection, enabling better control measures within poultry populations and refining regional surveillance strategies.In a related examination of zoonotic potential, Markarian and Abrahamyan (https://doi.org/10.3389/fmicb.2024.1486792) synthesize recent advances in Sosuga virus research, emphasizing progress in understanding its replication dynamics and pathogenic determinants. Given the virus's origin in bat reservoirs and its phylogenetic affinity to highly pathogenic paramyxoviruses such as Nipah and Hendra viruses, the authors argue for the urgent expansion of One Health-based surveillance frameworks to better characterize spillover risks and improve preparedness for potential future outbreaks.Emerging viral diversity is also evident in the study by Hu et al., (https://doi.org/10.3389/fmicb.2024.1500146) who report the presence of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) in Jiangxi Province and identify segmental reassortment events among genotypes C4, C5, and J1. Although viral RNA was not detected in animal or tick samples collected around confirmed cases, phylogenomic and recombination analyses demonstrated clear evidence of genetic exchange. The identification of reassortant strains in humans but not in sampled vectors or reservoir hosts suggests gaps in ecological sampling and highlights the ongoing need for comprehensive surveillance in regions experiencing newly recognized transmission. Diagnostic capacity likewise emerges as a central theme in the work of Wang et al., (https://doi.org/10.3389/fmicb.2025.1475273) who developed a highly sensitive duplex qPCR assay capable of distinguishing between classical (GI) and variant...